Image

Global Transfection Technologies Market – Industry Trends and Forecast to 2030

  • Healthcare
  • Upcoming Report
  • Nov 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60
  • Healthcare
  • Upcoming Report
  • Nov 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Transfection Technologies Market, By Transfection Method (Cotransfection, Electroporation, Cationic Lipid Transfection, Lipofection, Nucleofection, In Vivo Transfection), Product (Reagent, Instrument, Others), Applications (Virus Production, Protein Production, Gene Silencing, Stem Cell Reprogramming and Differentiation, Stable Cell Line Generation, Therapeutic Delivery, Bio-Medical Research, Protein Production, Others), Technology (Physical Transfection, Biochemical Based Transfection, Viral-Vector Based Transfection), End-user (Pharmaceutical and biotechnology companies, Contract research organizations, Academic and research institutes) – Industry Trends and Forecast to 2030.

Transfection Technologies Market

Transfection Technologies Market Analysis and Size

The market for transfection technologies will expand rapidly due to rising cancer incidences and increased research and development in cell-based therapies. As the prevalence of cancer rises and the number of obese people rises, so the demand for transfection also rises. This factor is propelling the market for transfection technologies. Furthermore, initiatives taken by various government organizations amplify the market's growth.

Data Bridge Market Research analyses that the transfection technologies market which was USD 1073.22 million in 2022, is expected to reach USD 2001.22 million by 2030, at a CAGR of 8.1% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Transfection Technologies Market Scope and Segmentation  

Report Metric

Details

Forecast Period

2023 to 2030

Base Year

2022

Historic Years

2021 (Customizable to 2015 - 2020)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

Transfection Method (Cotransfection, Electroporation, Cationic Lipid Transfection, Lipofection, Nucleofection, In Vivo Transfection), Product (Reagent, Instrument, Others), Applications (Virus Production, Protein Production, Gene Silencing, Stem Cell Reprogramming and Differentiation, Stable Cell Line Generation, Therapeutic Delivery, Bio-Medical Research, Protein Production, Others), Technology (Physical Transfection, Biochemical Based Transfection, Viral-Vector Based Transfection)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Market Players Covered

Lonza (Switzerland), Promega Corporation (U.S.), Thermo Fisher Scientific Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Roche Molecular Systems, Inc. (U.S.), QIAGEN (Germany), Inovio Pharmaceuticals (U.S.), Polyplus Transfection (France), Mirus Bio LLC (U.S.), Takara Bio Inc. (Japan), SignaGen Laboratories (U.S.), MaxCyte, Inc. (U.S.), Genlantis Inc. (U.S.), Techulon (U.S.), BioAstrum Corporation (U.S.), Altogen Biosystems (U.S.), OZ Biosciences (France), Boca Scientific, Inc. (U.S.), Biontex Laboratories GmbH (Germany)

Market Opportunities

  • Technological Advancements

Market Definition

Transfection technology introduces nucleic acids into cells, such as Deoxyribonucleic Acid (DNA), Ribonucleic Acid (RNA), and oligonucleotides. It is introduced through various physical, chemical, and biological methods that can aid in modifying certain cell properties. Cotransfection, electroporation, cationic lipid transfection and in-vivo transfection are all methods used. This method is commonly used in genomic studies such as gene expression, screening, RNA interference, and Vivo research, as well as the bioproduction of viruses and proteins.

Global Transfection Technologies Market Dynamics

Drivers

  • Introduction of new products

Co-transfection is the introduction of more than one type of nucleic acid into a eukaryotic cell. Multiple plasmid DNAs, siRNA and plasmid DNA, and multiple miRNAs into the same cell are instances of combinations. Multiple plasmid DNA co-transfection generally aims to introduce more than one type of foreign gene into host cells. One of its applications is the creation of synthetic viral or hybrid vectors comprised of multiple plasmid DNA components. An example is the generation of a lentivirus from several plasmid vectors such as transfer, envelope, and packaging vectors in HEK293 cell line. These are some of the instances which propel the growth of market.

  • Rise in transfection efficiency

Transfection efficiency can be determined by co-transfection of small RNA and plasmid DNA. This is possible by inserting a plasmid containing a luciferase reporter gene whose 3′ UTR can be recognised by a specific small RNA such as miRNA, allowing the small RNA to bind and inhibit luciferase expression. On the other hand, Co-transfection of small RNA and plasmid DNA, is required in RNA interference (RNAi) research to determine the regulatory effects of a specific small RNA, such as siRNA, on specific gene expression in a host cell.

Opportunities

  • Technological advancements

Co-transfection may also involve other small molecules, such as miRNAs, which can be used to study the effects of small RNAs on targeted host cells. For instance, if the introduction of a miRNA mimic can affect the expression of a specific downstream gene in a specific cell type, the simultaneous transfection of its inhibitor sequence into the same cell is expected to reduce the post-transcriptional regulatory effect exerted by the miRNA mimics sequence alone.

Restraints/Challenges

  • High cost

The cost of transfection technology instruments and home brew reagents are the major factors acting as restraints. They will further challenge the growth of the transfection technologies market during the forecast period.

This transfection technologies market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the transfection technologies market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Transfection Technologies Market Scope

The transfection technologies market is segmented on the basis of transfection method, technology, end-user, and applications. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Application

  • Virus Production
  • Protein Production
  • Gene Silencing
  • Stem Cell Reprogramming and Differentiation
  • Stable Cell Line Generation
  • Therapeutic Delivery
  • Bio-Medical Research
  • Protein Production
  • Others

Transfection Method

  • Lipofection
  • Eletroporation
  • Nucleofection
  • Cotransfection
  • Cationic Lipid Transfection
  • In-Vivo Transfection
  • Others

Technology

  • Physical Transfection
  • Biochemical Based Transfection
  • Viral-Vector Based Transfection

End-User

  • Pharmaceutical and biotechnology companies
  • Contract research organizations
  • Academic and research institutes

Transfection Technologies Market Regional Analysis/Insights

The transfection technologies market is analyzed and market size insights and trends are provided by country, transfection method, technology, end-user and applications as referenced above.

The countries covered in the transfection technologies market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the transfection technologies market because of an increase in the number of cases of infectious diseases requiring antibiotics and an increase in the use of cell-based products requiring transfection methods to treat chronic diseases such as cancer, tuberculosis, and cardiovascular diseases in this region.

Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2023 to 2030 owing to increase in the occurrences of cancer diseases in this region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed base and New Technology Penetration

The transfection technologies market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for transfection technologies market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the transfection technologies market. The data is available for historic period 2011-2021.

Competitive Landscape and Transfection Technologies Market Share Analysis

The transfection technologies market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to transfection technologies market.

Some of the major players operating in the transfection technologies market are:

  • Lonza (Switzerland)
  • Promega Corporation (U.S.)
  • Thermo Fisher Scientific Inc. (U.S.)
  • Bio-Rad Laboratories, Inc. (U.S.)
  • Roche Molecular Systems, Inc. (U.S.)
  • QIAGEN (Germany)
  • Inovio Pharmaceuticals (U.S.)
  • Polyplus Transfection (France)
  • Mirus Bio LLC (U.S.)
  • Takara Bio Inc. (Japan)
  • SignaGen Laboratories (U.S.)
  • MaxCyte, Inc. (U.S.)
  • Genlantis Inc. (U.S.)
  • Techulon (U.S.)
  • BioAstrum Corporation (U.S.)
  • Altogen Biosystems (U.S.)
  • OZ Biosciences (France)
  • Boca Scientific, Inc. (U.S.)
  • Biontex Laboratories GmbH (Germany)

Research Methodology: Global Transfection Technologies Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Customization Available

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.


SKU-
Why Choose Us


Frequently Asked Questions

The Transfection Technologies Market is projected to grow at a CAGR of 8.1% during the forecast period by 2030.
The future market value of the Transfection Technologies Market is expected to reach USD 2001.22 million by 2030.
The major players in the Transfection Technologies Market are Lonza (Switzerland), Promega Corporation (U.S.), Thermo Fisher Scientific Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Roche Molecular Systems, Inc. (U.S.), QIAGEN (Germany), Inovio Pharmaceuticals (U.S.), etc.
The countries covered in the Transfection Technologies Market are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, etc.